Details for New Drug Application (NDA): 071842
✉ Email this page to a colleague
NDA 071842 describes GENERLAC, which is a drug marketed by Chartwell Rx and Morton Grove and is included in two NDAs. It is available from one supplier. Additional details are available on the GENERLAC profile page.
The generic ingredient in GENERLAC is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
The generic ingredient in GENERLAC is lactulose. There are twenty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the lactulose profile page.
Summary for 071842
| Tradename: | GENERLAC |
| Applicant: | Morton Grove |
| Ingredient: | lactulose |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 071842
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;ORAL, RECTAL | Strength | 10GM/15ML | ||||
| Approval Date: | Sep 27, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
